Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 2
2007 1
2008 5
2009 4
2010 8
2011 7
2012 13
2013 15
2014 9
2015 11
2016 6
2017 11
2018 13
2019 5
2020 11
2021 4
2022 15
2023 9
2024 4
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project.
Faghihi-Kashani S, Yoshida A, Bozan F, Zanframundo G, Rozza D, Loganathan A, Dourado E, Sambataro G, Bauer-Ventura I, Bae SS, Lim D, Rivero-Gallegos D, Yamano Y, Selva-O'Callaghan A, Mammen AL, Scirè CA, Montecucco C, Oddis CV, Fiorentino D, Bonella F, Miller FW, Lundberg IE, Schmidt J, Rojas-Serrano J, Hudson M, Kuwana M, González-Gay MA, McHugh N, Corte TJ, Doyle TJ, Werth VP, Gupta L, Perez Roman DI, Bianchessi LM, Devarasetti PK, Shinjo SK, Luppi F, Cavazzana I, Moghadam-Kia S, Fornaro M, Volkmann ER, Piga M, Loarce-Martos J, De Luca G, Knitza J, Wolff-Cecchi V, Sebastiani M, Schiffenbauer A, Rider LG, Campanilho-Marques R, Marts L, Bravi E, Gunawardena H, Aggarwal R, Cavagna L; Classification Criteria for Anti‐Synthetase Syndrome Project participating investigators. Faghihi-Kashani S, et al. Arthritis Rheumatol. 2025 Apr;77(4):477-489. doi: 10.1002/art.43038. Epub 2024 Dec 17. Arthritis Rheumatol. 2025. PMID: 39467037 Free PMC article.
CXCL10 in psoriasis.
Ferrari SM, Ruffilli I, Colaci M, Antonelli A, Ferri C, Fallahi P. Ferrari SM, et al. Among authors: colaci m. Adv Med Sci. 2015 Sep;60(2):349-54. doi: 10.1016/j.advms.2015.07.011. Epub 2015 Aug 12. Adv Med Sci. 2015. PMID: 26318079 Review.
Paraneoplastic rheumatic disorders: a narrative review.
Manzini CU, Colaci M, Ferri C, Manzini E. Manzini CU, et al. Among authors: colaci m. Reumatismo. 2018 Dec 20;70(4):199-211. doi: 10.4081/reumatismo.2018.1069. Reumatismo. 2018. PMID: 30570238 Free article. Review.
Renal Manifestations of Hepatitis C Virus.
Ferri C, Giuggioli D, Colaci M. Ferri C, et al. Among authors: colaci m. Clin Liver Dis. 2017 Aug;21(3):487-497. doi: 10.1016/j.cld.2017.03.005. Epub 2017 Apr 27. Clin Liver Dis. 2017. PMID: 28689588 Free article. Review.
HCV-Related Rheumatic Manifestations and Therapeutic Strategies.
Sebastiani M, Giuggioli D, Colaci M, Fallahi P, Gragnani L, Antonelli A, Zignego AL, Ferri C. Sebastiani M, et al. Among authors: colaci m. Curr Drug Targets. 2017;18(7):803-810. doi: 10.2174/1389450116666150907103622. Curr Drug Targets. 2017. PMID: 26343108 Review.
Novel Therapies for Thyroid Autoimmune Diseases.
Fallahi P, Ferrari SM, Elia G, Nasini F, Colaci M, Giuggioli D, Vita R, Benvenga S, Ferri C, Antonelli A. Fallahi P, et al. Among authors: colaci m. Expert Rev Clin Pharmacol. 2016 Jun;9(6):853-61. doi: 10.1586/17512433.2016.1157468. Epub 2016 Mar 8. Expert Rev Clin Pharmacol. 2016. PMID: 26900630 Review.
IP-10 in autoimmune thyroiditis.
Ruffilli I, Ferrari SM, Colaci M, Ferri C, Fallahi P, Antonelli A. Ruffilli I, et al. Among authors: colaci m. Horm Metab Res. 2014 Aug;46(9):597-602. doi: 10.1055/s-0034-1382053. Epub 2014 Jun 30. Horm Metab Res. 2014. PMID: 24977661 Review.
138 results